Completed from United Kingdom
Absolutely brilliant! The course blew me away with its depth and relevance. I learned to use decision‑tree modelling to evaluate new therapies, and the live workshops gave me the chance to ask questions about real‑world data sources. The reading pack included the latest NICE guidelines, which made the content instantly useful for my role in a UK health‑technology assessment consultancy. I’m thrilled with how much my analytical toolkit has grown—highly recommend to anyone eager to master pharma health economics!
The Pharmaceutical Health Economics module at Stanmore School of Business perfectly aligned with my professional development plan. The rigorous focus on cost‑effectiveness analysis allowed me to complete a real‑world case study on pricing strategies for a new oncology drug, which I later presented to my employer. The course materials—especially the interactive Excel models and up‑to‑date policy briefs—were clear, concise, and directly applicable to my work in a biotech firm. Overall, the instruction was highly professional and the learning outcomes exceeded my expectations.
I signed up for the pharma health economics course hoping to get a solid grounding, and it delivered! The mix of video lectures and hands‑on assignments helped me finally grasp how to calculate QALYs and apply them to real drug pricing decisions. One cool thing was the group project where we built a budget impact model for a vaccine rollout—something I can actually use in my public‑health job. The materials were up‑to‑date and easy to follow, and I left the course feeling confident and ready to tackle more complex analyses.
The Pharmaceutical Health Economics course was a meticulously designed program that helped me achieve several specific learning objectives. Firstly, it clarified the theoretical foundations of health economic evaluation, enabling me to differentiate between cost‑utility, cost‑benefit, and cost‑effectiveness analyses. Secondly, the practical sessions on building Markov models using R provided hands‑on experience; I successfully created a model for a chronic disease treatment pathway, which I later incorporated into a research paper submitted to a local journal. The course materials—comprising detailed slide decks, peer‑reviewed articles, and a comprehensive data‑set repository—were both current and highly relevant to the Indian pharmaceutical market. Overall, the learning experience was engaging and the instructor’s feedback was prompt and insightful, leaving me satisfied with the knowledge and skills acquired.
